Scarica l'app Stockscreener
7.18
2.57%
0.18
Dopo l'orario di chiusura:
7.30
0.12
+1.67%
Exagen Inc Borsa (XGN) Ultime notizie
Exagen Appoints Chas McKhann to Board of Directors - TipRanks
Exagen Inc. Appoints Chas McKhann to Board of Directors - AInvest
Exagen appoints Chas McKhann to board of directors - Investing.com Australia
Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan
Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire
What makes Exagen Inc. stock price move sharplyFree Expert Investment Advice - Newser
How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser
Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest
Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Quiver Quantitative
Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan
Why Exagen Inc. stock attracts strong analyst attentionTrending Stock Alert - Newser
Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener
Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener
Exagen Insider Ups Holding During Year - Yahoo
Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest
Exagen announces resale of up to 1.15M shares - MSN
Exagen appoints Michael Mahler as CSO - TipRanks
Leading Autoimmune Researcher Dr. Mahler Joins Exagen: 300+ Publications and Game-Changing Diagnostic Patents - Stock Titan
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus
Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
2.54%
3.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):